1. Home
  2. IH vs RANI Comparison

IH vs RANI Comparison

Compare IH & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$2.19

Market Cap

116.0M

Sector

Real Estate

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.40

Market Cap

134.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IH
RANI
Founded
1996
2012
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.0M
134.6M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
IH
RANI
Price
$2.19
$1.40
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.67
AVG Volume (30 Days)
9.3K
2.6M
Earning Date
12-19-2025
11-06-2025
Dividend Yield
3.88%
N/A
EPS Growth
N/A
N/A
EPS
0.29
N/A
Revenue
$123,215,612.00
$1,200,000.00
Revenue This Year
$39.02
$414.59
Revenue Next Year
N/A
$30.15
P/E Ratio
$7.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.55
$0.39
52 Week High
$3.60
$3.87

Technical Indicators

Market Signals
Indicator
IH
RANI
Relative Strength Index (RSI) 38.84 42.10
Support Level $2.15 $1.40
Resistance Level $2.40 $1.53
Average True Range (ATR) 0.12 0.11
MACD 0.00 -0.00
Stochastic Oscillator 21.44 15.00

Price Performance

Historical Comparison
IH
RANI

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: